ZEKE CAPITAL ADVISORS, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
ZEKE CAPITAL ADVISORS, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$262,000
+13.4%
1,537
-6.5%
0.02%
-22.2%
Q3 2020$231,000
+0.9%
1,643
+15.1%
0.03%
-38.6%
Q2 2020$229,000
-66.8%
1,428
-73.3%
0.04%
-22.8%
Q4 2019$689,000
+88.8%
5,343
+10.1%
0.06%
+78.1%
Q3 2019$365,000
-57.0%
4,852
-13.1%
0.03%
-60.0%
Q2 2019$849,000
+9.5%
5,585
-14.1%
0.08%
+11.1%
Q1 2019$775,000
-21.2%
6,502
-27.8%
0.07%
-23.4%
Q4 2018$983,000
+32.3%
9,008
+95.8%
0.09%
+54.1%
Q3 2018$743,000
+68.5%
4,600
+37.8%
0.06%
+48.8%
Q2 2018$441,000
+83.0%
3,337
+2.7%
0.04%
+86.4%
Q1 2018$241,0003,2490.02%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 112,689$14,541,00014.93%
Casdin Capital, LLC 670,000$86,457,0007.95%
Logos Global Management LP 226,002$29,163,0007.19%
Avoro Capital Advisors LLC 1,760,000$227,110,0006.67%
Camber Capital Management LP 600,000$77,424,0003.94%
STANSBERRY ASSET MANAGEMENT, LLC 71,133$9,179,0003.74%
Eventide Asset Management 996,000$128,524,0003.62%
CADIAN CAPITAL MANAGEMENT, LP 550,000$70,972,0003.14%
RTW INVESTMENTS, LP 605,762$78,168,0002.95%
Consonance Capital Management LP 356,145$45,957,0002.80%
View complete list of SAREPTA THERAPEUTICS INC shareholders